Skip to main content
. 2009 Feb 18;9:60. doi: 10.1186/1471-2407-9-60

Figure 1.

Figure 1

Cancer onset age in the BRCA1/2 mutation carriers (A) and BRCA1/2 non carriers (B), according to their MDM2 SNP-309 subtypes. C and D prevalence of the SNP MDM309 genotypes in women above and bellow 51 years old – C total carrier population and D only BRCA1 mutation carriers.